Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13D/A | 2024-03-25 | Kellnerova Renata | Autolus Therapeutics plc | 14,612,275 | 5.5% | EDGAR |
SC 13D | 2024-02-21 | BioNTech SE | Autolus Therapeutics plc | 33,333,333 | 12.5% | EDGAR |
SC 13G/A | 2024-02-14 | Paradigm Biocapital Advisors LP | Autolus Therapeutics plc | 12,611,335 | 7.2% | EDGAR |
SC 13G/A | 2024-02-14 | Deep Track Capital, LP | Autolus Therapeutics plc | 11,869,297 | 6.8% | EDGAR |
SC 13G/A | 2024-02-14 | ARMISTICE CAPITAL, LLC | Autolus Therapeutics plc | 3,850,000 | 2.2% | EDGAR |
SC 13G/A | 2024-02-13 | Syncona Portfolio Ltd | Autolus Therapeutics plc | 33,527,162 | 14.4% | EDGAR |
SC 13G/A | 2024-01-31 | Tetragon Financial Management LP | Autolus Therapeutics plc | 8,000,000 | 4.6% | EDGAR |
SC 13G | 2023-07-10 | Paradigm Biocapital Advisors LP | Autolus Therapeutics plc | 10,098,584 | 5.8% | EDGAR |
SC 13G | 2023-03-20 | Tetragon Financial Management LP | Autolus Therapeutics plc | 9,461,883 | 5.5% | EDGAR |
SC 13G/A | 2023-02-14 | Nantahala Capital Management, LLC | Autolus Therapeutics plc | 7,782,018 | 4.7% | EDGAR |
SC 13G/A | 2023-02-14 | Deep Track Capital, LP | Autolus Therapeutics plc | 15,000,000 | 8.7% | EDGAR |
SC 13G/A | 2023-02-14 | Syncona Portfolio Ltd | Autolus Therapeutics plc | 33,527,162 | 19.7% | EDGAR |
SC 13G/A | 2023-02-14 | Frazier Life Sciences Public Fund, L.P. | Autolus Therapeutics plc | 3,025,906 | 1.7% | EDGAR |
SC 13G | 2023-02-14 | ARMISTICE CAPITAL, LLC | Autolus Therapeutics plc | 10,224,000 | 5.9% | EDGAR |
SC 13G/A | 2023-02-13 | Capital World Investors | Autolus Therapeutics plc | 625,000 | 0.4% | EDGAR |
SC 13G | 2022-12-19 | Deep Track Capital, LP | Autolus Therapeutics plc | 15,000,000 | 9.0% | EDGAR |
SC 13D/A | 2022-12-13 | Blackstone Inc. | Autolus Therapeutics plc | 23,750,917 | 14.0% | EDGAR |
SC 13G | 2022-12-13 | Qatar Investment Authority | Autolus Therapeutics plc | 15,000,000 | 9.0% | EDGAR |
SC 13D/A | 2022-10-05 | PPF Biotech B.V. | Autolus Therapeutics plc | 14,612,275 | 16.1% | EDGAR |
SC 13G | 2022-02-14 | Nantahala Capital Management, LLC | Autolus Therapeutics plc | 4,077,509 | 5.6% | EDGAR |